Search Results
Is venetoclax in combination with low-dose cytarabine a safe regimen for the treatment of AML?
Venetoclax in combination with low-dose cytarabine – a promising regimen for the treatment of AML
For Older AML Patients, Venetoclax With Low-Dose Cytarabine is Safe and “Promising”
Safety and Efficacy of Venetoclax Plus Low-dose Cytarabine
VEN-A-QUI: low-dose cytarabine or azacitidine+venetoclax and quizartinib in older patients with AML
Is venetoclax combined with low-dose chemo and HMA safe and efficacious in older patients with AML?
Is venetoclax + low dose ara-C + actinomycin D safe and effective in patients with AML?
Safety and efficacy of venetoclax plus LDAC in treatment-naive AML patients aged ≥ 65 years
Comparison of venetoclax-based versus non-venetoclax-based treatment regimens in AML
Venetoclax-Based Combination Therapies Revolutionize Paradigm for Elderly AML
Venetoclax in AML updates: approval & combinations
Phase I/II study of milademetan plus low-dose cytarabine with or without venetoclax in R/R AML
